---
figid: PMC5445595__41531_2017_13_Fig3_HTML
figtitle: T cell gene expression analyses of T cells from sargramostim-treated or
  placebo-treated PD patients
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Mycobacterium tuberculosis variant bovis BCG
- Fundulus heteroclitus
organisms_ner:
- Homo sapiens
- Mus musculus
- Fundulus heteroclitus
- Danio rerio
pmcid: PMC5445595
filename: 41531_2017_13_Fig3_HTML.jpg
figlink: /pmc/articles/PMC5445595/figure/Fig3/
number: F3
caption: T cell gene expression analyses of T cells from sargramostim-treated or placebo-treated
  PD patients. a Significant increase or decrease in expression of genes by CD4+CD25−
  T cells from PD patients treated with sargramostim compared with placebo. Genes
  are divided into those associated with Th1 and Th17 (Pro-inflammatory), Th2 and
  Tregs (Anti-inflammatory), and general T cell proliferation and differentiation
  (Non-associated). Significant differences are indicated by a heat map. The map ranged
  from 40-fold increase (red) to 40-fold decrease (green). b Ingenuity pathway analyses
  performed on upregulated or downregulated genes to identify putative network associations
  involved in hematological development and T cell function. Genes and mediators that
  are upregulated are shaded red with the darker shades indicating more upregulation;
  shades of green denote downregulation; and nodes in white represent putative-associated
  function
papertitle: Evaluation of the safety and immunomodulatory effects of sargramostim
  in a randomized, double-blind phase 1 clinical Parkinson’s disease trial.
reftext: Howard E. Gendelman, et al. NPJ Parkinsons Dis. 2017;3:10.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7744123
figid_alias: PMC5445595__F3
figtype: Figure
redirect_from: /figures/PMC5445595__F3
ndex: 15929edc-dea2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5445595__41531_2017_13_Fig3_HTML.html
  '@type': Dataset
  description: T cell gene expression analyses of T cells from sargramostim-treated
    or placebo-treated PD patients. a Significant increase or decrease in expression
    of genes by CD4+CD25− T cells from PD patients treated with sargramostim compared
    with placebo. Genes are divided into those associated with Th1 and Th17 (Pro-inflammatory),
    Th2 and Tregs (Anti-inflammatory), and general T cell proliferation and differentiation
    (Non-associated). Significant differences are indicated by a heat map. The map
    ranged from 40-fold increase (red) to 40-fold decrease (green). b Ingenuity pathway
    analyses performed on upregulated or downregulated genes to identify putative
    network associations involved in hematological development and T cell function.
    Genes and mediators that are upregulated are shaded red with the darker shades
    indicating more upregulation; shades of green denote downregulation; and nodes
    in white represent putative-associated function
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNF
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - RORC
  - IL32
  - IL22
  - IL37
  - IL23A
  - CSF3
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNK
  - IFNW1
  - IFNB1
  - IL4
  - IL3
  - RPL18
  - IGKV1D-13
  - IGKV1-13
  - IFNL1
  - FASLG
  - FAS
  - FASN
  - TNC
  - TNN
  - TNR
  - TNXB
  - EOMES
  - IGSF6
  - LRRC32
  - PPARG
  - IGKV3D-11
  - IL12B
  - SPACA9
  - SPG21
  - IL15
  - IL10
  - IL6
  - CXCR1
  - IRF8
  - IL24
  - IGKV3D-7
  - LILRB2
  - NELFCD
  - IRF4
  - RPL23
  - IGKV1D-43
  - IL17F
  - QRSL1
  - GATA1
  - GATA2
  - GATA3
  - GATA4
  - GATA5
  - GATA6
  - TP53
  - PERP
  - IGKV6D-21
  - LBX1
  - CENPE
  - KIF11
  - KIF12
  - KIF13A
  - KIF13B
  - KIF14
  - KIF15
  - KIF16B
  - KIF17
  - KIF18A
  - KIF18B
  - KIF19
  - KIF1A
  - KIF1B
  - KIF1C
  - KIF20A
  - KIF20B
  - KIF21A
  - KIF21B
  - KIF22
  - KIF23
  - KIF24
  - KIF25
  - KIF26A
  - KIF26B
  - KIF27
  - KIF2A
  - KIF2B
  - KIF2C
  - KIF3A
  - KIF3B
  - KIF3C
  - KIF4A
  - KIF4B
  - KIF5A
  - KIF5B
  - KIF5C
  - KIF6
  - KIF7
  - KIF9
  - KIFC1
  - KIFC2
  - KIFC3
  - STARD9
  - TAS2R6P
  - TP53INP1
  - UTS2
  - Tnf
  - Rorc
  - Il22
  - Il23a
  - Csf3
  - Pbrgcsf1
  - Ifna
  - Il4
  - Il3
  - Rpl18
  - Fasl
  - Fas
  - Fasn
  - Eomes
  - Igsf6
  - Lrrc32
  - Pparg
  - Spg21
  - Spaca9
  - Il15
  - Il10
  - Il6
  - Ccr8
  - Irf8
  - Il24
  - Ap2a2
  - Hand2
  - Hand1
  - Nelfcd
  - Irf4
  - Il17f
  - Qrsl1
  - Gata4
  - Trp53
  - Perp
  - Phgdh
  - Hoxa
  - Tas2r145-ps3
  - Trp53inp1
  - Ass1
  - Uts2
  - tnfa
  - rorc
  - faslg
  - fas
  - eomesb
  - lrrc32
  - pparg
  - il10
  - irf8
  - th2
  - gata4
  - tp53
  - tp53inp1
  - tnfb
  - kita
  - ngfra
  - rorca
  - il22
  - csf3b
  - csf3a
  - il13
  - il4
  - eomesa
  - cnp
  - il15
  - ifnphi1
  - tnfrsfa
  - il6
  - puf60b
  - perp
  - msx3
  - lbx2
  - Leucine
  - Serotonin
  - L-tryptophan
---
